Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market Report

Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Dec 21, 2019
  • PAGES：188
  • REPORT CODE：GMM405886
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Oral Solid Dosage Forms (OSDF) and Pharma Excipients market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.7% during the forecast period.

    This report presents the market size and development trends by detailing the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oral Solid Dosage Forms (OSDF) and Pharma Excipients market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oral Solid Dosage Forms (OSDF) and Pharma Excipients industry and will help you to build a panoramic view of the industrial development.

    Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, By Type:

    • Glycerin

    • Propylene Glycol

    • Sorbitol

    • Mannitol

    • Others

    Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market, By Application:

    • Industrial Application

    • Non-industrial Application

    Some of the leading players are as follows:

    • J.M. Huber Corporation

    • ABITEC Corporation

    • DOW Chemical Company

    • Evonik

    • BASF

    • Eastman Chemical Company

    • JM Huber Corporation

    • Cargill

    • Archer Daniels Midland (ADM)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Technology Type Analysis

    • 4.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Glycerin

      • 4.3.2 Propylene Glycol

      • 4.3.3 Sorbitol

      • 4.3.4 Mannitol

      • 4.3.5 Others

    5 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Product Analysis

    • 5.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Market Share Analysis, 2018 & 2026

    • 5.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Application Analysis

    • 6.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Application Market Share Analysis, 2018 & 2026

    • 6.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Industrial Application

      • 6.3.2 Non-industrial Application

    7 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Market: Regional Analysis

    • 7.1 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regional Market Share Analysis, 2018 & 2026

    • 7.2 Oral Solid Dosage Forms (OSDF) and Pharma Excipients Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 J.M. Huber Corporation

      • 9.1.1 J.M. Huber Corporation Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 ABITEC Corporation

      • 9.2.1 ABITEC Corporation Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 DOW Chemical Company

      • 9.3.1 DOW Chemical Company Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Evonik

      • 9.4.1 Evonik Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 BASF

      • 9.5.1 BASF Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Eastman Chemical Company

      • 9.6.1 Eastman Chemical Company Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 JM Huber Corporation

      • 9.7.1 JM Huber Corporation Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Cargill

      • 9.8.1 Cargill Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Archer Daniels Midland (ADM)

      • 9.9.1 Archer Daniels Midland (ADM) Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

     

    The List of Tables and Figures (Totals 60 Figures and 130 Tables)

    • Figure Glycerin Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, 2015 - 2026 (USD Million)

    • Figure Propylene Glycol Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, 2015 - 2026 (USD Million)

    • Figure Sorbitol Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, 2015 - 2026 (USD Million)

    • Figure Mannitol Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, 2015 - 2026 (USD Million)

    • Figure Others Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, 2015 - 2026 (USD Million)

    • Figure Industrial Application market, 2015 - 2026 (USD Million)

    • Figure Non-industrial Application market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by country, 2015 - 2026 (USD Million)

    • Table North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table North America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Canada Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by country, 2015 - 2026 (USD Million)

    • Table Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Europe Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Germany Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table France Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table France Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Italy Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Spain Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Spain Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table China Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table China Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Japan Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table India Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table India Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table MEA Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by country, 2015 - 2026 (USD Million)

    • Table MEA Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table MEA Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table MEA Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Oral Solid Dosage Forms (OSDF) and Pharma Excipients market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table J.M. Huber Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ABITEC Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table DOW Chemical Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Evonik Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BASF Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Eastman Chemical Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table JM Huber Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cargill Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Archer Daniels Midland (ADM) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US